Muller-Vahl_2021_Pharmacopsychiatry__

Reference

Title : Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study - Muller-Vahl_2021_Pharmacopsychiatry__
Author(s) : Muller-Vahl KR , Fremer C , Beals C , Ivkovic J , Loft H , Schindler C
Ref : Pharmacopsychiatry , : , 2021
Abstract : Muller-Vahl_2021_Pharmacopsychiatry__
ESTHER : Muller-Vahl_2021_Pharmacopsychiatry__
PubMedSearch : Muller-Vahl_2021_Pharmacopsychiatry__
PubMedID: 34847610

Related information

Citations formats

Muller-Vahl KR, Fremer C, Beals C, Ivkovic J, Loft H, Schindler C (2021)
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study
Pharmacopsychiatry :

Muller-Vahl KR, Fremer C, Beals C, Ivkovic J, Loft H, Schindler C (2021)
Pharmacopsychiatry :